Sell RIM!: Against ...
Health Care: Drugs
Bionovo Inc. (BNVI: OTC)
$0.02 0.00 | -13.79%
06/04/12 - 10:42 AM ET
Company Cash Flow
Cash Flow data is not available for BNVI.
Portfolios with BNVI
- Portfolio NameUser Type
- Contributor16 Small-Cap Stocks in Dang...
- UserTom's Stock Picks
- UserEmerging biotech
- UserCougar Investment Playa Club
- Userswcarconsulting Portfolio 1
- UserASPSC
- Userteamjolly1 Portfolio 1
- Userlosers24
- Userbj's money
- UserSUPRATRADE-BIOTECH
Latest BNVI Headlines from TheStreet
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- 16 Small-Cap Stocks in Danger of Delisting 03.30.11 | 07:03 am
- Zale, Huntington Bancshares: Midday Volume Plays 04.21.10 | 10:04 am
- EnteroMedics, Bionovo: Early Volume Plays 01.14.10 | 09:01 am
- Trimeris, Bionovo: Early Volume Plays 12.29.09 | 09:12 am
- Friday's Small-Cap Winners & Losers 10.26.07 | 05:10 pm
- Street Smiles on Women's Health-Focused Biotech
06.27.07 | 12:06 pm - Stock Upgrades, Downgrades From TheStreet.com Ratings 06.01.07 | 12:06 pm
Press Releases for BNVI
- Bionovo's Independent Data Safety Monitoring Board Recommends Continuation Of Phase 3 Study For Menerba⢠- PR Newswire 03.28.12 | 11:03 am
- Bionovo Enters Into Agreement For Offering Of Common Stock And Warrants - PR Newswire 03.12.12 | 11:03 am
- Bionovo Restructures Work Force Management Compensation Restructured - PR Newswire 03.09.12 | 08:03 pm
- Bionovo President & CMO Receives Women Of The Year Award - PR Newswire 03.08.12 | 08:03 am
- Bionovo To Present At Cowen And Company 32nd Annual Health Care Conference - PR Newswire 03.01.12 | 08:03 am
- Bionovo Files Registration Statement For Offering Of Convertible Preferred Stock And Warrants - PR Newswire 02.29.12 | 04:02 pm
- Bionovo Announces Decision To Explore Strategic Options And To Delay Announcement Of Financial Results For 2011 - PR Newswire 02.21.12 | 08:02 am
- Bionovo To Host Conference Call To Discuss 2011 Highlights And Year-End Financial Results - PR Newswire 02.16.12 | 08:02 am
- Bionovo Announces Findings Of Bezielle⢠Anticancer Properties And Active Principles - PR Newswire 02.07.12 | 08:02 am
- Bionovo To Voluntarily Delist From NASDAQ - PR Newswire 01.27.12 | 04:01 pm
Partner Headlines for BNVI
- Noteworthy Institutional 5% Ownership Filings This Week - Seeking Alpha 03.22.12 | 08:03 am
- Bionovo to Voluntarily Delist from NASDAQ - Benzinga 01.27.12 | 04:01 pm
- Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes - Benzinga 10.26.11 | 04:10 pm
- UPDATE 1-Bionovo gets FDA nod for lead drug development, shrs up - Reuters 11.10.10 | 10:11 am
- Investment Opportunities in Women's Health - Seeking Alpha 06.04.10 | 04:06 pm
